@article{edba1e81ea3b47c38550d071f0cf6f5f,
title = "The 2019 medical genetics workforce: A focus on laboratory geneticists",
abstract = "Purpose: The aim of this report is to inform the genetics and genomics field about the results of a 2019 workforce survey of US laboratory geneticists. Methods: The American Board of Medical Genetics and Genomics distributed an electronic survey to board-certified/eligible diplomates in 2019. Analysis of the responses was performed by the American College of Medical Genetics and Genomics. Results: A total of 422 individuals identified as laboratory geneticists. The respondents represent the range of possible certifications. Nearly one-third were Clinical Cytogenetics and Genomics diplomates, another third were Molecular Genetics and Genomics diplomates, and the others were Clinical Biochemical Genetics diplomates or held a combination of certificates. The majority of laboratory geneticists are PhDs. The others were physicians or other degree combinations. Most laboratory geneticists work in academic medical centers or commercial laboratories. Most respondents identified as females and White. The median age was 53 years. A third of the respondents have been in the profession for 21+ years and plan to reduce hours or retire in the next 5 years. Conclusion: The genetics field needs to foster the next generation of laboratory geneticists to meet the increasing complexity and demand for genetic testing.",
keywords = "Genetics workforce, Genomics workforce, Laboratory geneticists",
author = "Maiese, {Deborah R.} and Megan Lyon and Reddi, {Honey V.} and Blitzer, {Miriam G.} and Bodurtha, {Joann N.} and Maximilian Muenke",
note = "Funding Information: The content is solely the responsibility of the author(s) and does not necessarily represent the official views of the ACMG. This project was supported by the Health Resources and Services Administration of the US Department of Health and Human Services under #UH9MC30770 from 6/17 to 5/20 for $800,000 per award year. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by the Health Resources and Services Administration, Health and Human Services, or the US Government. Conceptualization: D.R.M. M.L. M.G.B. J.N.B. M.M.; Funding Acquisition: M.M.; Investigation: D.R.M. M.L. H.V.R. M.G.B. J.N.B. M.M.; Methodology: D.R.M. M.L. H.V.R. M.G.B. J.N.B. M.M.; Writing-original draft: D.R.M. M.L.; Writing-review and editing: H.V.R. M.G.B. J.N.B. M.M. The Johns Hopkins University Institutional Review Board deemed the survey's deidentified results exempt (secondary research protocol). This exemption was approved on January 10, 2020. The survey was administered via ABMGG, and NCC staff did not have access to the distribution tool, nor was identifying information collected in the survey. NCC staff had access to the survey results; ABMGG did not. Only a summary analysis was provided to ABMGG. Dr. Anita Berryman an NCC consultant, conducted the data analysis, and she was provided the deidentified survey results to perform analysis. Funding Information: This project was supported by the Health Resources and Services Administration of the US Department of Health and Human Services under #UH9MC30770 from 6/17 to 5/20 for $800,000 per award year. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by the Health Resources and Services Administration, Health and Human Services, or the US Government. Publisher Copyright: {\textcopyright} 2023 The Authors",
year = "2023",
month = jun,
doi = "10.1016/j.gim.2023.100834",
language = "English (US)",
volume = "25",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "6",
}